European Medicines Agency (EMA) Accepts Veloxis' Marketing Authorization ... Wall Street Journal (press release) For Investor and media contact: John Weinberg, M.D. EVP & Chief Commercial Officer Phone: +1 732 321 3208 Email: jdw@veloxis.com About LCP--Tacro(TM) and tacrolimus Tacrolimus is a leading immunosuppression drug used for the prevention of ... |
